Provided by Tiger Fintech (Singapore) Pte. Ltd.

Palisade Bio Inc.

1.16
+0.05004.50%
Post-market: 1.12-0.0400-3.45%19:59 EDT
Volume:1.52M
Turnover:1.84M
Market Cap:5.56M
PE:-0.21
High:1.29
Open:1.13
Low:1.12
Close:1.11
Loading ...

Company Profile

Company Name:
Palisade Bio Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
8
Office Location:
7750 El Camino Real,Suite 2A,Carlsbad,California,United States
Zip Code:
92009
Fax:
- -
Introduction:
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.

Directors

Name
Position
Donald Williams
Director, Chairman
J. D. Finley
Chief Executive Officer, Chief Financial Officer and Director
Binxian Wei
Director
Emil Chuang
Director

Shareholders

Name
Position
J. D. Finley
Chief Executive Officer, Chief Financial Officer and Director
Mitchell Jones
Chief Medical Officer